Quality of life with talazoparib versus physician’s choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial - Concepedia

Concepedia

Publication | Open Access

Quality of life with talazoparib versus physician’s choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial

DOI Full Paper Access

135

Citations

14

References

2018

Year

Johannes Ettl, Ruben G.W. Quek, Ki Hoon Lee, Hope S. Rugo, Sara A. Hurvitz, Anthony Gonçalvès, Louis Fehrenbacher, Rinat Yerushalmi, Lida A. Mina, Miguel Martín,

Annals of Oncology

Abstract

NCT01945775.

References

	Year	Citations

Page 1